{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T05:20:17Z","timestamp":1733462417513,"version":"3.30.1"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":204,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.lrr.2024.100471","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:41:48Z","timestamp":1722037308000},"page":"100471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Chronic myeloid leukemia with involvement of membranous labyrinth"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6354-072X","authenticated-orcid":false,"given":"Mobachir El","family":"Kettani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashish","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hareem","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talha","family":"Badar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2024.100471_bib0001","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00277-003-0829-4","article-title":"CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid","volume":"83","author":"Bornhauser","year":"2004","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.lrr.2024.100471_bib0002","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0194-59989570095-1","article-title":"Bilateral sensorineural hearing loss as a first symptom of chronic myelogenous leukemia","volume":"113","author":"Genden","year":"1995","journal-title":"Otolaryngol\u2013Head Neck Surg."},{"issue":"10","key":"10.1016\/j.lrr.2024.100471_bib0003","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/0003489418787831","article-title":"Sudden bilateral hearing loss, tinnitus, and vertigo as presenting symptoms of chronic myeloid leukemia","volume":"127","author":"Cass","year":"2018","journal-title":"Ann. Otol. Rhin. Laryngol."},{"issue":"1","key":"10.1016\/j.lrr.2024.100471_bib0004","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41408-023-00891-x","article-title":"Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events","volume":"13","author":"Abdelmagid","year":"2023","journal-title":"Blood Cancer J."},{"issue":"24","key":"10.1016\/j.lrr.2024.100471_bib0005","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa1902328","article-title":"Asciminib in chronic myeloid Leukemia after ABL kinase inhibitor failure","volume":"381","author":"Hughes","year":"2019","journal-title":"New Engl. J.Med"},{"issue":"2","key":"10.1016\/j.lrr.2024.100471_bib0006","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.24275","article-title":"Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring","volume":"91","author":"Jabbour","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.lrr.2024.100471_bib0007","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/10428190310001625728","article-title":"Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571)","volume":"45","author":"Leis","year":"2004","journal-title":"Leuk. Lymphoma"},{"issue":"12","key":"10.1016\/j.lrr.2024.100471_bib0008","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00405-007-0382-1","article-title":"Unilateral sudden hearing loss as the first sign of chronic myeloid leukemia","volume":"264","author":"Acar","year":"2007","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"issue":"12","key":"10.1016\/j.lrr.2024.100471_bib0009","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/1097-0142(19851215)56:12<2865::AID-CNCR2820561225>3.0.CO;2-6","article-title":"Dessypris EN. Chronic lymphocytic leukemia with hyperleukocytosis the hyperviscosity syndrome","volume":"56","author":"Baer","year":"1985","journal-title":"Cancer"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221304892400061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221304892400061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T20:37:24Z","timestamp":1733431044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221304892400061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":9,"alternative-id":["S221304892400061X"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2024.100471","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic myeloid leukemia with involvement of membranous labyrinth","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2024.100471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100471"}}